Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,542,808
-$640,717 QoQ
Shares Held
3,400,496
-10.4% QoQ
Ownership
3.74%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,148,963,746 across 191 Biotechnology names. CDXS ranks #69 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,542,808 | 3,400,496 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,183,525 | 3,793,574 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,767,696 | 2,773,646 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,223,966 | 2,550,806 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,818,361 | 2,534,707 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $11,446,330 | 2,399,650 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,352,036 | 2,387,025 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,208,509 | 2,002,745 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,533,764 | 1,299,073 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,758,127 | 1,232,173 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,378,642 | 1,787,642 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,978,045 | 706,445 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,264,989 | 788,645 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $3,802,904 | 816,074 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $11,882,980 | 1,960,888 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,765,976 | 1,602,866 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $56,734,670 | 2,751,439 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $73,266,296 | 2,343,022 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $47,134,342 | 2,026,412 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $36,915,087 | 1,629,086 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $23,395,960 | 1,022,104 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $22,343,419 | 1,023,519 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,974,279 | 764,419 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,714,889 | 764,464 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,520,369 | 763,474 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||